Rx · PZN 08866420

RALNEA 4 mg prolonged-release tablets

German trade nameRALNEA 4 mg Retardtabletten

Active ingredientRopiniroleSubstance (DE)RopinirolPharmaceutical formProlonged-release tablets

Only sporadically available

0.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Extended ambient max. 30 °C

Highest known
purchase price (B2B)

~ €129

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for RALNEA 4 mg prolonged-release tablets.

Review purchasing terms

RALNEA 4 mg prolonged-release tablets contains the active ingredient Ropinirole (German Ropinirol) and comes as Prolonged-release tablets. One pack size is recorded (PZN 08866420). The pharma availability index for German wholesale stands at 0.6 out of 10 over the past 30 days – the pack was therefore only sporadically available.

RALNEA 4 mg prolonged-release tablets was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.